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Clinical value of tone burst vestibular evoked myogenic
potentials at threshold in acute and stable Me´nie`re’s
disease
V OSEI-LAH, B CERANIC*, L M LUXON
Abstract
Introduction: The objectives of this preliminary, prospective, cohort study were to ascertain the
characteristics of vestibular evoked myogenic potentials at threshold levels in two groups of Me´nie`re’s
disease patients – acute and stable – and to identify whether vestibular evoked myogenic potentials
can provide any specific, objective information to distinguish acute from stable Me´nie`re’s disease.
Subjects and methods: The study was based at a tertiary neuro-otology centre. Twenty adult patients
who fulfilled the American Academy of Otolaryngology–Head and Neck Surgery1 criteria for
Me´nie`re’s disease were divided into two groups: 11 patients with acute Me´nie`re’s disease and nine
patients with stable Me´nie`re’s disease. Eighteen healthy adult volunteers served as controls. All
subjects underwent vestibular evoked myogenic potential testing with ipsilateral, short tone burst
stimuli at 500 Hz, as well as pure tone audiometry. The patients also underwent caloric testing.
Results: Vestibular evoked myogenic potentials were present in all controls, and were present in 65 per
cent of patients but absent in 35 per cent. The mean absolute threshold (Tvestibular evoked myogenic
potential)+ standard deviation in normal controls was 116+ 7.7 dBSPL; this did not differ statistically
from that in patients, nor did it differ between acute and stable Me´nie`re’s disease. The p13/n23
latencies at the threshold levels in the normal, acute and stable groups (mean+ standard deviation)
were respectively: 15+ 2.2 ms/23.0+ 2.5 ms; 15.7+ 0.9 ms/23.7+ 0.9 ms; and 15.3+ 2.0 ms/24.2+
1.9 ms. The mean interaural amplitude difference ratio (IAD)+ standard deviation was significantly
higher in the stable group compared with the acute group (0.54+ 0.33 vs 20.15+ 0.22; p ¼ 0.007) and
with the controls (0.54+ 0.33 vs 0.1+ 0.22; p ¼ 0.05).
Conclusions: The parameter that best differentiated acute from stable Me´nie`re’s disease at threshold
was the interaural amplitude difference ratio. Therefore, this parameter may be used to monitor the
clinical course of Me´nie`re’s disease.
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Introduction
The recording of vestibular evoked myogenic poten-
tials is emerging as a useful tool in clinical vestibular
practice. Clinical and experimental studies have
suggested that vestibular evoked myogenic potentials
are generated by saccular afferents in response to
loud acoustic stimuli, and may be recorded by
surface electrodes on a tonically contracted sterno-
cleidomastoid muscle.2,3 The putative pathway for
ipsilateral vestibular evoked myogenic potential is
the saccule, inferior vestibular nerve, lateral vestibu-
lar nucleus, lateral vestibulospinal tract and the ster-
nocleidomastoid muscle (Figure 1).
Me´nie`re’s disease is an inner-ear disorder with an
entirely unpredictable clinical course. The pathophy-
siology is unknown, although endolymphatic hydrops
is believed to be the main histopathological correlate.
The disease in its typical form is characterised by acute
phases (exacerbation), with attacks of aural fullness,
vertigo, tinnitus and hearing loss, separated by variable
periods of remission (stable phase). The underlying
mechanism for such a clinical course is unclear. Fur-
thermore, at present, several tests are used to charac-
terise Me´nie`re’s disease, including the caloric test,
electronystagmography, electrocochleography and
osmotic tests. However, results are highly variable,
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such that no one test is diagnostic. Moreover, all these
tests may cause some degree of discomfort.
Vestibular evoked myogenic potentials are
thought to provide specific information about the
saccule, which, according to histological studies, is
the most common site of morphological alteration
in the vestibular labyrinth.4,5 Thus, the recording of
vestibular evoked myogenic potentials could be a
suitable test for Me´nie`re’s disease, as it is easy to
perform, non-invasive and well tolerated. It is there-
fore anticipated that vestibular evoked myogenic
potentials could be used in cases of Me´nie`re’s
disease to: aid understanding of the pathophysiology;
aid diagnosis (particularly regarding early detection
of contralateral ear involvement); and monitor the
clinical course of the disease.
There have been a number of reports on vestibular
evoked myogenic potentials in Me´nie`re’s disease,
with variable results.
De Waele et al.6 studied 59 patients with Me´nie`re’s
disease and reported absent vestibular evoked myo-
genic potentials (in response to clicks) in 54 per
cent of patients; this result correlated with the
degree of low frequency hearing loss and poor pos-
tural performance, but not with canal paresis.
Seo et al.7 reported a case of saccular hydrops in a
patient presenting with non-rotatory disequilibrium,
in which a depressed vestibular evoked myogenic
potential amplitude recovered to normal after furo-
semide administration. The same group8 sub-
sequently demonstrated an increase in p13-n23
amplitude in seven of 18 cases and the reappearance
of vestibular evoked myogenic potentials in three out
of seven cases after furosemide loading. These results
suggest that reversal of reflex attenuation is due to
reduction of saccular hydrops following diuresis.
However, in those in whom vestibular evoked
myogenic potentials remained absent after furose-
mide loading, severe hydrops might have caused irre-
versible saccular degeneration.
Detection of either absent or reduced vestibular
evoked myogenic potential amplitudes has been
widely reported.9 – 12 Kuo et al.13 reported abnormal
vestibular evoked myogenic potentials (absent or
depressed) in eight out of 12 Me´nie`re’s disease
patients within 24 hours of an acute attack;
however, in four of those patients, vestibular
evoked myogenic potentials returned to normal
after 48 hours. These authors postulated that abnor-
mal vestibular evoked myogenic potentials were due
to saccular hydrops affecting oscillation of the endo-
lymph, whereas the reappearance of vestibular
evoked myogenic potentials could be attributed to
drainage of the saccular hydrops.
Although most studies have focussed on amplitude
changes, recent reports indicate that threshold is prob-
ably a more reliable measure of vestibular evoked
myogenic potential changes in Me´nie`re’s disease.14,15
Lin et al.15 reported elevated mean vestibular
evoked myogenic potential thresholds in affected
ears and also, to a lesser extent, in contralateral
asymptomatic ears, compared with normal controls.
They concluded that vestibular evoked myogenic
potentials could be used to predict contralateral ear
involvement and eventual bilateral Me´nie`re’s disease.
The distinct characteristics of vestibular evoked
myogenic potentials in acute and stable Me´nie`re’s
disease are unknown. Therefore, this study examined
vestibular evoked myogenic potentials in normal sub-
jects and in patients with Me´nie`re’s disease, and also
compared results for patients in the acute and stable
phases of the disease.
Materials and methods
Subjects
Twenty patients who fulfilled the American
Academy of Otolaryngology–Head and Neck
Surgery1 criteria for Me´nie`re’s disease, and who
attended a tertiary neuro-otology clinic at the
National Hospital for Neurology and Neurosurgery,
London, were recruited for the study. All patients
were interviewed to obtain a full clinical history
and underwent a full clinical neuro-otological exam-
ination. The acute (exacerbation) group (11 patients)
consisted of those who had had an attack in the pre-
ceding three months and were still symptomatic. The
stable (remission) group (nine patients) had been
free of attacks and symptoms for more than three
months. Eighteen healthy volunteers (36 ears) aged
between 18 and 60 years, with no history of neuro-
logical or otological disease, acted as controls.
The study was approved by the joint ethics com-
mittee of the National Hospital for Neurology and
Neurosurgery and the Institute of Neurology.
Methods
Audiovestibular tests. Pure tone audiometry was
performed in all subjects.16 The patients also under-
went immitance audiometry,16 transient evoked
FIG. 1
Pathway for ipsilateral vestibular evoked myogenic potential.
S ¼ superior vestibular nucleus; M ¼ medial vestibular
nucleus; L ¼ lateral vestibular nucleus; D ¼ descending
vestibular nucleus; LVST ¼ lateral vestibulospinal tract;
MLF ¼ medial longitudinal fasciculus; SCM ¼
sternocleidomastoid muscle.
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oto-acoustic emissions,17 direct current electronystag-
mography, and caloric testing by the Fitzgerald–
Hallpike technique, according to the standard protocol
of the National Hospital for Neurology and Neuro-
surgery, neuro-otology department.18
Recording of vestibular evoked myogenic potentials.
The sternocleidomastoid muscle was used as the
target muscle. Subjects were tested while laying on
a couch with the head rest adjusted 308 to the hori-
zontal plane. Surface electromyography (EMG)
was recorded by attaching Ag/AgCl electrodes on
the mid-point of the sternocleidomastoid muscle
(active), the mid-clavicle (negative) and the upper
sternum (ground). From the recumbent position,
subjects were instructed to lift their head up, in
order to activate both sternocleidomastoid muscles
symmetrically; a 500 Hz short tone burst (1 ms rise
and fall, 2 ms plateau) was then delivered via TDH
49 calibrated headphones (Telephonics Corporation,
New York, New York, USA), mono-aurally at a rate
of 4.7 Hz, using the Medelec Synergy EMG/EP
system (Oxford Instruments Limited, Surrey, UK).
Tone bursts instead of clicks were used because the
former involved less scatter of energy at suprathres-
hold level. A frequency of 500 Hz was used because
this is the frequency reported to best differentiate
normal from abnormal responses at threshold.19
Electromyographic signals were amplified, band
pass filtered between 20 and 2000 Hz, and sampled
for 100 ms. Two hundred stimuli were averaged for
each test run. The stimulus was delivered at 130
dBSPL to elicit the initial positive (p13) and negative
(n23) waves ipsilateral to the stimulus (Figure 2). The
stimulus was then reduced in 5 dB steps and the
minimum intensity required to elicit a p13-n23
response was taken to be the threshold of stimu-
lation, designated Tvestibular evoked myogenic
potential. For each p13-n23 waveform, the
peak-to-peak amplitude of the unrectified EMG
was measured, as was the amplitude of the rectified
EMG which reflected the degree of muscle acti-
vation. The latencies of p13 and n23 were measured
and the interaural amplitude difference and ratio,
as well as the interaural threshold difference and
ratio, were computed.
The Statistical Package for the Social Sciences
version 11 software (SPSS Inc, Chicago, Illinois,
USA) was used for data analyses. The Student
t-test was used to compare the results of the two
patient groups, side-to-side differences, and differ-
ences between affected ears and control ears.
Comparisons of the results for the three subject
groups were performed using one-way analysis of
variance, with Bonferroni corrections for multiple
comparisons. A significance level of 0.05 was used.
Results and analysis
The study included 12 female and six male controls
with a mean age of 34.1 years (standard deviation
(SD), 5.9 years; range, 26–49 years).
The characteristics of the patients are summarised
in Table I. The mean age of the Me´nie`re’s disease
patients was 48.5 years (SD, 11.3 years; range, 20–
61 years) and their median duration of illness was
4.5 years (range, 1–22 years). There were 10
women and 10 men. Eleven (55 per cent) patients
had acute Me´nie`re’s disease and nine (45 per cent)
had stable disease. In 11 (55 per cent) and nine (45
per cent) patients, the affected side was the left and
right, respectively. According to the American
Academy of Otolaryngology–Head and Neck
Surgery criteria, 16 (80 per cent) were classified as
having definite Me´nie`re’s disease, whereas two (10
per cent) each had possible and probable disease.
Four patients had normal caloric test responses, and
one patient did not undergo the test because of an
in situ grommet. The remaining patients had significant
canal paresis in the affected ear, ranging between 8 and
100 per cent (normal canal paresis, for this department,
was less than 8 per cent) (Table I).
Vestibular evoked myogenic potential results
The mean+SD threshold (Tvestibular evoked myo-
genic potential) for the controls (36 ears) was 116+
7.7 dBSPL (+104.5 dBnHL). Vestibular evoked
myogenic potentials were present in 13 (65 per
cent) of the 20 affected ears. Of the seven (35 per
cent) affected ears without a measurable vestibular
evoked myogenic potential, two had acute disease
and five had stable disease. Thus, vestibular evoked
myogenic potentials were recorded in 81 per cent of
the acute group but in only 44 per cent of the
stable group. There was no correlation between the
duration of Me´nie`re’s disease and the presence or
absence of vestibular evoked myogenic potentials.
The mean+SD Tvestibular evoked myogenic poten-
tial for the affected ears in the acute and stable
groups were respectively 118+ 7.9 dBSPL and
120+4.0 dBSPL. The same parameter in non-
affected patient ears was 117+5.3 dBSPL. There
was no statistical difference in Tvestibular evoked
myogenic potential between acute and stable
patients, control ears and affected ears, and control
ears and non-affected ears (Table II).
Twelve patients underwent vestibular evoked myo-
genic potential testing for both sides (affected and
non-affected). Of these, vestibular evoked myogenic
potentials were absent bilaterally in three, absent on
FIG. 2
Vestibular evoked myogenic potential (VEMP) p13/n23 wave
complex.
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the diseased side only in two and absent on the non-
diseased side in a further two patients. Thus, in five
patients, vestibular evoked myogenic potentials
were absent in the non-affected ear.
The mean+SD p13 and n23 latencies at threshold
in the controls were respectively 15+2.2 ms and 23+
2.5 ms. Statistically, these results did not differ from
the respective results for the affected ears in the
acute group (15.7+0.9 ms and 23.7+0.9 ms), the
stable group (15.3+2.0 ms and 24.2+1.9 ms) or the
non-affected Me´nie`re’s disease ears (15.1+0.8 ms
and 23.6+1.1 ms). Although absolute latencies in
the patients were within normal limits, p13 latency
was shorter with longer duration of Me´nie`re’s
disease (R¼ 2 0.73; p ¼ 0.004) (Figure 3).
The mean+SD corrected amplitudes (the ratio of
tonic EMG and amplitude) did not differ between
groups, being 1.7+ 0.5, 1.9+0.5 and 2.5+ 1.1 for
normal controls, acute ears and stable affected ears,
respectively. The mean+SD interaural amplitude
difference ratios (i.e. right to left amplitude differ-
ence divided by the sum of amplitudes) for controls
and for acute and stable Me´nie`re’s disease affected
ears were respectively 0.1+0.22, 20.15+ 0.22 and
0.54+0.33. The mean+SD interaural amplitude
difference ratio was significantly higher in the stable
group compared with the acute group (0.54+0.33
vs 20.15+ 0.22; p ¼ 0.007) and with the controls
(0.54+ 0.33 vs 0.1+ 0.22; p ¼ 0.05). Interaural
threshold difference and interaural threshold differ-
ence ratios were determined for all groups, but differ-
ences did not reach statistical significance.
Discussion
This study compared vestibular evoked myogenic
potential characteristics at threshold levels in
patients with acute and stable Me´nie`re’s disease,
using 500 Hz short tone burst stimuli. It has been
widely reported that vestibular evoked myogenic
potentials are frequency-sensitive in healthy individ-
uals, as reflected in the ‘frequency tuning curves’.
Although Todd et al.20 reported maximum vestibular
evoked myogenic potential amplitude responses of
between 300 and 350 Hz, the optimum frequency of
the tone burst in healthy adults has been reported
to be 500 Hz.19,21 In the study by Rauch et al., 19
poorer tuning was apparent in Me´nie`re’s disease
patients at 500 Hz, and this was the frequency that
best differentiated normal from diseased subjects.
However, this ‘best’ frequency can lie between 500
and 1000 Hz22 or between 500 and 700 Hz.23 The
TABLE I
CHARACTERISTICS OF ME´NIE`RE’S DISEASE PATIENTS
Subject Sex Age (yr) Acute/stable MD MD side MD class MD duration (yr) Canal paresis (%) VEMP present?
1 F 36 Acute L Definite 10 100 Y
2 F 40 Acute L Definite 3 10 N
3 M 50 Acute R Possible 4 78 Y
4 M 61 Acute L Definite 10 NA Y
5 F 60 Acute R Definite 3 8 Y
6 F 20 Acute L Probable 5 39 Y
7 M 49 Acute L Definite 3 20 Y
8 M 61 Acute R Definite 10 8 N
9 M 48 Acute R Definite 2 9 Y
10 M 58 Acute L Definite 1 13 Y
11 F 53 Acute R Definite 6 51 Y
12 F 58 Stable R Possible 6 20 Y
13 M 51 Stable L Definite 10 20 N
14 M 52 Stable L Definite 4 NA N
15 F 41 Stable R Probable 1 Grommet Y
16 F 39 Stable L Definite 8 15 N
17 M 28 Stable L Definite 3 5 N
18 F 50 Stable L Definite 2 17 Y
19 F 54 Stable R Definite 22 15 Y
20 M 60 Stable R Definite 8 NA N
Yr ¼ years; MD ¼Me´nie`re’s disease; VEMP ¼ vestibular evoked myogenic potential; F ¼ female; M ¼ male; L ¼ left; R ¼ right;
Y ¼ yes; N ¼ no; NA ¼ no asymmetry
TABLE II
VEMP CHARACTERISTICS OF CONTROLS AND OF AFFECTED AND NON-AFFECTED EARS
VEMP parameter Controls Affected ears Non-affected ears
Acute Stable
TVEMP (dBSPL) 116+ 7.7 118+ 7.9 120+4.0 117+ 5.3
p13 (ms) 15+ 2.2 15.7+ 0.9 15.3+2.0 15.1+ 0.8
n23 (ms) 23.0+ 2.5 23.7+ 0.9 24.2+1.9 23.6+ 1.1
Amplitude (mV) 43.2+ 19.4 39.2+ 19.9 26.8+8.8 60.8+ 58.5
Corrected amplitude 1.7+ 0.5 1.9+ 0.5 2.5+1.1 2.0+ 1.2
Data are presented as mean+ standard deviation. VEMP ¼ vestibular evoked myogenic potential; TVEMP ¼ mean absolute
VEMP threshold
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alteration in tuning and threshold shift in Me´nie`re’s
disease has been attributed to the presumed hydropic
distension of the saccule.23
In this study, Tvestibular evoked myogenic poten-
tial was 116+7.7 dBSPL. The threshold vestibular
evoked myogenic potential response in healthy
adults ranges between 11019 and 114.4 dBSPL.22
The apparent differences may be due to differences
in methodology.
Studies reporting threshold changes in Me´nie`re’s
disease are few. In contrast to the present study, in
which there was no statistically significant Tvestibular
evoked myogenic potential difference between the
ears of healthy volunteers and the affected and non-
affected ears of Me´nie`re’s disease patients, Rauch
et al.19 reported significantly elevated thresholds
both in the affected and unaffected ears of Me´nie`re’s
disease patients, compared with normal subjects. Lin
et al., 15 from the same centre, reported an elevated
mean vestibular evoked myogenic potential
threshold in affected ears and also, to a lesser
extent, in the contralateral asymptomatic ears, com-
pared with normal controls. These authors concluded
that the vestibular evoked myogenic potential
threshold can be used to predict contralateral ear
involvement and eventual bilateral Me´nie`re’s
disease; they also emphasised the importance of mul-
tifrequency testing to study the frequency tuning
characteristics in Me´nie`re’s disease.
In the present study, the vestibular evoked myo-
genic potential parameter that best differentiated
the three groups was the interaural amplitude differ-
ence ratio. This ratio was 0.10+ 0.22 for controls,
20.15+0.22 for acute Me´nie`re’s disease affected
ears and 0.54+0.33 for stable Me´nie`re’s disease
affected ears. In the literature, there is no infor-
mation on values using tone burst, but for click-
evoked vestibular evoked myogenic potential, a
normal interaural amplitude difference ratio range
of 0.14+0.11 (mean+1 SD) has been reported.9
These same authors reported a positive correlation
between interaural amplitude difference ratios and
the stage of disease, i.e. the higher the stage, the
higher the ratio. This was not the case in our study,
probably due to the small sample size. We found
that the interaural amplitude difference ratio was sig-
nificantly higher in stable disease when compared
with acute disease (p ¼ 0.007) and with controls
(p ¼ 0.05). Although the number of patients in our
study was small, the interaural amplitude difference
ratio appears to be a promising parameter for moni-
toring Me´nie`re’s disease progression; further
research is needed to refine its clinical utility.
Rauch et al.14 reported that, in unilateral Me´nie`re’s
disease, the interaural threshold difference correctly
assigned side-of-disease in 85 per cent of cases. In
this study, the interaural threshold difference did
not vary between groups, probably due to differences
in methodology and sample size.
. Vestibular evoked myogenic potentials are
generated by saccular afferents in response to
loud acoustic stimuli
. Ipsilateral vestibular evoked myogenic
potentials specifically assess saccular function
. The saccule is the commonest vestibular site
affected by Me´nie`re’s disease
. In this study, the interaural amplitude
difference ratio appeared to be a valuable
vestibular evoked myogenic potential
parameter that differentiated between acute
and stable Me´nie`re’s disease
. The interaural amplitude difference ratio may
be useful in monitoring the clinical course of
Me´nie`re’s disease
Latencies were normal in all groups. However, the
p13 latency correlated negatively with the duration of
Me´nie`re’s disease (R ¼ 20.73; p ¼ 0.004). The p13
latency was shorter with a longer duration of
Me´nie`re’s disease. The reason for this finding is not
clear. Latency changes are believed to reflect
changes within the central conducting pathways of
the vestibular evoked myogenic potential reflex.
Latency has been found to be stable in a variety of
peripheral vestibular disorders, including Me´nie`re’s
disease.11,24,25 Murofushi et al.24 also reported pro-
longed p13 latency both in patients with multiple
sclerosis and in those with a large vestibular schwan-
noma compressing the brainstem. They concluded
that lesions within the brainstem pathway of the ves-
tibulospinal tract are a prerequisite for the pro-
longation of p13. Similar findings were reported by
Alpini et al.,26 who attributed the prolonged latencies
in multiple sclerosis to demyelination, either of the
primary afferent axons at the root entry zone or of
secondary vestibulospinal tract axons. However, a
few studies have reported prolonged p13 and n23
latencies in Me´nie`re’s disease, attributed to a high
endolymphatic pressure in the saccule, impairing
sound transmission.9,27 One possible explanation
for the latency findings in this study could be retro-
grade degeneration in Scarpa’s ganglion and the
vestibular nerve, reducing the conduction velocity
of the vestibular evoked myogenic potential reflex
as the disease progresses, although there are
FIG. 3
Correlation between p13 latency and Me´nie`re’s disease
duration.
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conflicting reports as to whether this occurs in
Me´nie`re’s disease. Spoendlin et al.28 and Kitamura
et al.29 reported degeneration and decrease in vestib-
ular nerve fibres, whereas Ylikoski et al.30 and Kita-
mura et al.31 found no such evidence.
Conclusion
The recording of vestibular evoked myogenic poten-
tials is an emerging, non-invasive vestibular function
test which can be applied to Me´nie`re’s disease. The
interaural amplitude difference ratio appears to be
a valuable parameter which can be used to monitor
the clinical course of the disease, and in particular
to identify the acute phase of Me´nie`re’s disease so
as to guide appropriate treatment. However, in
order to refine its clinical utility and to recommend
its routine use in Me´nie`re’s disease, large, prospec-
tive, controlled, longitudinal vestibular evoked myo-
genic potential studies (during different phases of
Me´nie`re’s disease) are required, in order to deter-
mine the sensitivity and specificity of the various ves-
tibular evoked myogenic potential parameters.
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